OHSU

Charles Keller

Head Shot of Charles Keller

Associate Professor

Email: 
click here

Background

Dr. Keller’s research focuses on the development of more effective, less toxic therapies for childhood sarcomas including the muscle cancer, rhabdomyosarcoma, and the childhood brain tumor, medulloblastoma. His laboratory's special interest is advanced disease that has spread beyond the initial location of the cancer. Dr. Keller is an Associate Professor and Leader of the Pediatric Cancer Biology Program in the Pape' Family Pediatric Research Institute, Department of Pediatrics. Dr. Keller also directs the Pediatric Preclinical Testing Initiative, an NCI-affiliated childhood cancer drug testing program. Dr. Keller previously attended Tulane University where he received a degree in Biomedical Engineering prior to attending Baylor College of Medicine where he received his M.D. degree. After completing his internship and residency in Pediatrics at Texas Children's Hospital, Dr. Keller trained in Pediatric Hematology-Oncology at the University of Utah.


Selected Publications

"Overcoming autopsy barriers in pediatric cancer research," Pediatric Blood and Cancer (Vol: 60, Issue: 2, Page 204-209) - 2013

"Protein kinase C iota as a therapeutic target in alveolar rhabdomyosarcoma," Oncogene (Vol: 32, Issue: 3, Page 286-295) - 2013

"CCAAT/enhancer binding protein beta is expressed in satellite cells and controls myogenesis," Stem Cells (Vol: 30, Issue: 12, Page 2619-2630) - 2012

"The Not-so-Skinny on Muscle Cancer," Cancer Cell (Vol: 22, Issue: 4, Page 421-422) - 2012

"An adaptive Src-PDGFRA-Raf axis in rhabdomyosarcoma," Biochemical and Biophysical Research Communications (Vol: 426, Issue: 3, Page 363-368) - 2012

 

OHSU Knight Cancer Institute

Visit Our Site

Contact

  Email Charles Keller

503 494-8311

Memberships & Associations

American Academy of Pediatrics
American Association for Cancer Research
Children’s Oncology Group